Australian Lab22 Prints Nitinol 3D Stents
Australian company Lab22 has successfully 3D printed stents using Nitinol, a shape-memory alloy.
Lab22, an Australian additive manufacturing company, has achieved a significant milestone by successfully 3D printing stents from Nitinol. Nitinol is a nickel-titanium alloy renowned for its shape-memory properties, meaning it can return to its original shape after being deformed. This characteristic makes it highly suitable for medical devices like stents, which need to expand and maintain their form within the body.
The development marks a step forward in the application of advanced materials in medical additive manufacturing. Traditional methods of producing Nitinol stents can be complex and costly. The ability to 3D print these devices offers potential advantages in customization and manufacturing efficiency.
While specific details regarding the printing process used by Lab22 were not provided in the source, the successful production of functional Nitinol stents highlights the growing capabilities of additive manufacturing in the biomedical field. This advancement could lead to more tailored and potentially more effective treatment options for patients requiring stenting procedures.
This development is significant as it demonstrates the increasing feasibility of 3D printing complex medical devices from advanced materials like Nitinol. The shape-memory properties of Nitinol are crucial for stent functionality, and additive manufacturing offers a pathway for customized, potentially more cost-effective production, advancing personalized medicine and implantable device innovation.
Edited by the news editor with AI and translated into English from the original report — please refer to the original source.